Numbers the anti-HCQ Brazil study is no more legitimate than the pro HCQ study done in France. They both dont pass mustard of a robust clinical trial. CNBC is being disingenuous blaming cardiac AEs on HCQ. Fact is nobody knows. The patients also received Z-Pack and Z-Pack is KNOWN to have cardiac AEs. Could have been Z-Pack for all we know plus they were severe patients. We already discussed ad nauseam that severe patients in cytokine storm will not be helped by an anti-viral. Let's wait for the large trials to conclude then we can judge HCQ good or bad.
Also, for altruistic reasons, cheap meds like HCQ and chlroquine will be helpful for countries with bad or non-existent healthcare systems. Do you think plasma therapy or even remdesivir would be viable in a country like Angola?
You're correct that neither is definitive, but I think the weight of evidence of the trials so far leans heavily towards lack of efficacy and several of my clinical expert colleagues agree, as does Derek Lowe and Dr. Bright, who was just sacked and the fact that HCQ is being used so much without any startlingly good results is enough for me to say that, at best, it's efficacy is marginal. Also, convalescent plasma is certainly viable in poor countries, with just a little help - hell, it was used in the 1890s and the 1918 pandemic.
Did you see Dr. Bright's comments after being sacked from his post at HHS, where he was deputy assistant secretary for preparedness and response and director of BARDA, the Biomedical Advanced Research and Development Authority (excerpted below)? Lowe and Bright are two of our best minds and I'll take their take on HCQ (as well as my friends' views).
https://blogs.sciencemag.org/pipeline/archives/2020/04/22/the-politics-of-hydroxychloroquine
“. . .To this point, I have led the government’s efforts to invest in the best science available to combat the Covid-19 pandemic. Unfortunately, this resulted in clashes with H.H.S. political leadership, including criticism for my proactive efforts to invest early into vaccines and supplies critical to saving American lives. I also resisted efforts to fund potentially dangerous drugs promoted by those with political connections.
Specifically, and contrary to misguided directives, I limited the broad use of chloroquine and hydroxychloroquine, promoted by the administration as a panacea, but which clearly lack scientific merit. While I am prepared to look at all options and to think ‘outside the box’ for effective treatments, I rightly resisted efforts to provide an unproven drug on demand to the American public. I insisted that these drugs be provided only to hospitalized patients with confirmed Covid-19 while under the supervision of a physician. . .”